AI Summary The SAFE score estimates liver scarring (fibrosis) risk in people with fatty liver disease, without a biopsy. It combines age, BMI, diabetes status, AST, ALT, globulin, and platelet count. Results below 0 are low, 0 to 99 intermediate, and 100 or higher high. Doctors use it to decide on monitoring, further tests such as FibroScan, or specialist care. It estimates risk and does not diagnose. Lifestyle changes remain the first step.
Source: www.liverdirectory.com
Medically Reviewed.
The SAFE score, short for Steatosis-associated Fibrosis Estimator, combines your age, body mass index (BMI), diabetes status, and a few routine blood results into one number. That number estimates your chance of having liver scarring (fibrosis) when you have fatty liver disease.
Your care team can calculate it without a liver biopsy. It is an estimate, not a diagnosis, and doctors read it alongside your other results.
Liver Health AI Assistant
Ask Aimy
Aimy answers from LiverDirectory’s reviewed health information — helping patients make sense of liver-health terms, prepare for specialist visits, and explore what to look up next.
Fatty Liver Fibrosis Estimate
The SAFE score is a clinical tool that estimates how much scarring (fibrosis) a person with fatty liver disease may have. Steatosis is the medical word for fat buildup in the liver.
Fatty liver disease is now often called metabolic dysfunction-associated steatotic liver disease (MASLD). You may also see the older names NAFLD and, for the inflamed form, NASH, which is now called MASH. Read more on our fatty liver disease page.
The score uses measurements your care team already has: your age, BMI, whether you have diabetes, and routine blood results. A formula turns them into one number. That gives your doctor an estimate of fibrosis without a liver biopsy, the procedure that removes a small piece of liver tissue.
A SAFE score is one of several MAFLD / MASH scores. It estimates risk. It does not confirm a diagnosis.
Reasons for Fibrosis Screening
The SAFE score is meant for people who already have fatty liver disease or are at risk of it. Your doctor may use it in these situations.
Obesity, type 2 diabetes, and high cholesterol raise the chance of fatty liver disease and of liver scarring. Guidance says people over 50, people with type 2 diabetes, and people with metabolic syndrome should have liver enzymes and ultrasound as part of routine care.
A biopsy can cause pain and bleeding, and in rare cases serious problems. A score built from routine results is safer and can be repeated.
Doctors may recalculate the score to see how your liver responds to lifestyle changes or to treatment aimed at liver fat and inflammation.
The score helps estimate whether fatty liver disease could be moving toward advanced fibrosis or cirrhosis, so that any needed care starts early.
Score Inputs and Formula
Six pieces of information feed the formula. Most come from a routine blood draw and your clinic visit.
The formula. The published formula is: SAFE = 2.97 × Age + 5.99 × BMI + 62.85 × Diabetes + 154.85 × ln(AST) − 58.23 × ln(ALT) + 195.48 × ln(Globulin) − 141.61 × ln(Platelets) − 75. Your clinic or lab software does the math. You do not need to calculate it yourself.
Reading Your Result
A lower number means a lower estimated chance of advanced fibrosis. Your care team interprets the number with the rest of your health picture.
| SAFE score | Risk level | What it suggests | What usually happens next |
|---|---|---|---|
| Below 0 | Low | Advanced fibrosis is unlikely. | Routine monitoring and lifestyle measures. |
| 0 to 99 | Intermediate | Some fibrosis may be present. | Follow-up, monitoring, and further evaluation. |
| 100 or higher | High | Advanced fibrosis is likely. | Specialist assessment and possible treatment. |
Ask your care team which ranges your lab or clinic uses.
Follow-Up by Score Range
A SAFE score is a starting point. What happens next depends on your range, your other results, and your health history.
Your doctor will likely recommend routine monitoring and lifestyle measures. Ask how often to repeat your tests.
Expect follow-up, monitoring, and further evaluation. That may include a stiffness scan such as [FibroScan](/liver-tests/imaging-non-invasive-testing/elastography-fibrosis-testing) or another blood-based score. Guidance describes a stepwise approach, in which a simple score comes first and a second test confirms the result. This cuts down on unneeded biopsies.
Your doctor will likely advise a specialist assessment and may discuss treatment. A liver specialist can review your results and decide whether you need imaging, a biopsy, or both. Biopsy is usually kept for unclear results or to confirm advanced disease before some treatments. Use the search below to find a specialist.
Fibrosis Test Comparison
Doctors often combine tests instead of relying on one. Here is how the SAFE score fits in.
| Test | What it uses | What it tells you |
|---|---|---|
| SAFE score | Age, BMI, diabetes status, AST, ALT, globulin, and platelets | Estimates fibrosis risk in people with fatty liver disease |
| [FIB-4 and FIB-3](/liver-tests/medical-scores/fibrosis-scores) | Age, AST, ALT, and platelets | Estimates liver scarring from routine blood results |
| [APRI score](/liver-tests/medical-scores/fibrosis-scores/apri-score) | AST and platelet count | Estimates significant scarring from two blood values |
| [ELF score](/liver-tests/medical-scores/fibrosis-scores/elf-score) | Three special fibrosis markers in the blood | Gives a 0 to 10 fibrosis score |
| [FibroScan](/liver-tests/imaging-non-invasive-testing/elastography-fibrosis-testing) | Painless ultrasound-based probe on the skin | Measures liver stiffness and liver fat in about 10 to 15 minutes |
| [FAST score](/liver-tests/medical-scores/mafld-mash-scores/fast-score) | FibroScan results plus a blood test | Estimates MASH with significant fibrosis |
No single test is best for every person. Your care team chooses the mix that fits your situation.
Score Limitations and Context
The SAFE score estimates fibrosis risk. It does not show how much fat is in your liver, and it does not diagnose fatty liver disease. Ultrasound and other imaging do that.
Non-invasive scores work best at telling advanced fibrosis apart from milder stages. Scores such as FIB-4 are less accurate at spotting earlier stages of fibrosis. Your doctor may order a second test if your result falls in the middle range.
Age, BMI, diabetes, and blood values all change over time. One number is a snapshot. Your care team looks at the trend and your overall health.
The score is meant for people with fatty liver disease. It was not designed for other liver conditions, and it does not replace the advice of your liver specialist.
Lowering Your Risk
Scores show risk. Daily habits and medical care help lower it. Guidance for fatty liver disease centers on these steps.
Lifestyle change is the cornerstone of care for fatty liver disease. It means more physical activity, a healthier diet, and weight loss when your doctor advises it. These changes lower the risk that the disease progresses and improve markers of MASH.
Guidelines advise avoiding ultra-processed foods, added sugars such as fructose and high-fructose corn syrup, and excess saturated fat such as palm oil. Your care team or a dietitian can help you build a plan.
Guidelines recommend 150 to 240 minutes a week of moderate-to-vigorous aerobic exercise, such as brisk walking or cycling. That can lower liver fat by about 30%. Resistance training two to three days a week is also recommended. Check with your doctor before starting.
The FDA approved [resmetirom (Rezdiffra)](/liver-therapies/metabolic-masld-mash-therapies/thr-beta-agonist-therapy/resmetirom) in March 2024 for adults with MASH and moderate-to-advanced fibrosis (stages F2 to F3) who do not have cirrhosis. In August 2025, it approved semaglutide (Wegovy) for adults with MASH and fibrosis.
A biopsy or a non-invasive liver test can confirm who may benefit. Talk with your specialist about whether a medicine fits you. You can also read about [additional metabolic therapies](/liver-therapies/metabolic-masld-mash-therapies/additional-metabolic-therapies).
A balanced, liver-friendly diet supports your liver, helps manage weight and blood sugar, and lowers the risk of other health problems during long-term follow-up.
The Amsety Bar is a liver-friendly snack or meal replacement that can make it easier to eat well on busy days.
Shop Amsety Bars
Common Questions
The SAFE score is a calculation that estimates how likely liver fibrosis is in a person with fatty liver disease. Fibrosis means scarring of the liver. It combines your age, BMI, diabetes status, AST, ALT, globulin, and platelet count. A formula turns them into one number. Your doctor uses that number to judge whether you may have little scarring or more advanced scarring. It does not need a liver biopsy, so it is safer and can be repeated over time.
SAFE stands for Steatosis-associated Fibrosis Estimator. Each part of the name describes what the tool does. Steatosis means fat buildup in the liver. Fibrosis means scarring. An estimator gives an informed guess, not a final answer. So the name tells you that the score estimates scarring in people who have fat in the liver.
A score below 0 is the lowest-risk range. A score of 0 to 99 is intermediate, and a score of 100 or higher is high. A score below 0 means advanced fibrosis is unlikely. Your doctor will usually suggest routine monitoring and lifestyle measures. An intermediate score means some fibrosis may be present, so expect follow-up and possibly another test. A high score means advanced fibrosis is likely and calls for specialist assessment. Ask your care team which ranges your lab or clinic uses.
No. A high SAFE score means advanced fibrosis is likely, but the score is an estimate of risk, not a diagnosis. Cirrhosis is advanced scarring of the liver. Only your care team can tell whether you have it. A liver specialist will read your score together with your other results. They may order imaging, a biopsy, or both if the result is unclear or if they need to confirm advanced disease before some treatments.
Not usually. The score uses results most people with fatty liver disease already have. It needs your age, BMI, and diabetes status, plus routine blood results: AST, ALT, globulin, and platelet count. Your care team can calculate it from results you already have or from a standard blood draw. Your clinic or lab software does the math, so you do not need to work out the formula yourself.
Medical disclaimer: LiverDirectory provides educational information and a directory of providers. It does not provide medical advice, diagnosis, or treatment. Always consult a licensed physician regarding any medical condition.
